Mounjaro

Mounjaro® is a once-weekly tirzepatide injection approved for eligible adults with type 2 diabetes. Its dual GIP and GLP-1 activity helps improve blood sugar control and may also influence appetite and body weight.

Schedule Now about Mounjaro